Analytes/procedures in
bold type are regulated for proficiency testing by the Centers for Medicare & Medicaid Services (CMS).
This program assesses the laboratory’s ability to detect ALK-rearranged lung cancers using highly sensitive ALK immunohistochemistry. The ALK1 clone is not highly sensitive and should not be used in this program.
Program Information
- One 10‑core tissue microarray slide
Shipping Schedule
-
Shipment A: March 18
-
Shipment B: September 3